Zepbound Alternatives: Compounded Tirzepatide Online
How brand-name Zepbound compares with provider-prescribed compounded tirzepatide, plus the semaglutide option.
Zepbound (tirzepatide) is a highly effective FDA-approved weight-management medication, but cost and access keep many people from staying on it. If Zepbound is unaffordable or unavailable for you, there are alternatives worth discussing with a licensed provider.
Below we compare Zepbound with provider-prescribed compounded tirzepatide and compounded semaglutide, and explain how each option actually reaches you.
What is Zepbound?
Zepbound is Eli Lilly’s brand-name, once-weekly injectable for chronic weight management. Its active ingredient, tirzepatide, activates two gut hormone receptors (GLP-1 and GIP), which can help reduce appetite and improve metabolic markers. Mounjaro is the same molecule approved for type 2 diabetes.
Why people look for a Zepbound alternative
- Cost: Zepbound’s list price is roughly $1,000+ per month; Lilly’s self-pay vials are cheaper but still a stretch for many.
- Access: coverage for weight-loss medications is uneven, and supply has fluctuated.
- Preference: some patients want a telehealth provider who handles dose titration and side-effect management directly.
Zepbound vs. compounded tirzepatide
| Brand-name Zepbound | ZENKAI compounded tirzepatide | |
|---|---|---|
| Active ingredient | Tirzepatide | Tirzepatide |
| FDA status | FDA-approved | Compounded; not FDA-approved |
| Typical cost | ~$1,000+/mo list price | From $299/mo, cash-pay |
| Insurance | Sometimes covered (often excluded) | No insurance required |
| How you get it | Prescription at a retail pharmacy | Provider consult online, shipped to your door |
| Provider oversight | Yes | Yes — US-licensed provider reviews every case |
About compounded medications
Compounded semaglutide and tirzepatide are prepared by state-licensed 503A compounding pharmacies for an individual patient after a provider consultation. They are not FDA-approved products, are not reviewed by the FDA for safety or effectiveness, and are only appropriate when a licensed provider determines they are clinically suitable for you.
What about compounded semaglutide?
Semaglutide (the molecule in Wegovy and Ozempic) is a single-receptor GLP-1 option and is often less expensive than tirzepatide. Some patients start with semaglutide and switch if needed, or choose it for tolerability reasons. A provider can help you decide between the two based on your history and goals.
How ZENKAI works
Complete an online medical intake, have a US-licensed provider review your case, and — if appropriate — receive a provider-prescribed compounded medication from a state-licensed 503A pharmacy, shipped cold-chain to your door. Cash-pay, transparent pricing, ongoing support. Prescribing decisions are made independently by the provider.
See if a GLP-1 is right for you
Complete a short online intake. A US-licensed provider reviews your history and goals — no insurance required.
Start your free assessmentFrequently asked questions
Is compounded tirzepatide the same as Zepbound?
Both contain the active ingredient tirzepatide, but Zepbound is an FDA-approved branded product while compounded tirzepatide is prepared by a licensed 503A pharmacy for an individual patient and is not FDA-approved. A licensed provider decides whether it is appropriate for you.
Is compounded tirzepatide cheaper than Zepbound?
ZENKAI’s provider-prescribed compounded tirzepatide starts at $299/month cash-pay, which is typically lower than Zepbound’s list price. Costs and availability change, so confirm current pricing during your consultation.
Should I choose tirzepatide or semaglutide?
Both can support weight management but work slightly differently and differ in price. The right choice depends on your medical history, goals, and tolerance — a licensed provider will recommend what fits you.
How do I start?
Complete the online intake. A US-licensed provider reviews it, and if a GLP-1 is appropriate, your prescription ships to your door. No insurance required.
This page is for general education and is not medical advice. It does not establish a provider-patient relationship. Compounded semaglutide and tirzepatide are prepared by state-licensed 503A pharmacies, are not FDA-approved, and are only appropriate when a licensed provider determines they are suitable for you. Prescribing and treatment decisions are made independently by licensed providers. Results vary.